Your browser doesn't support javascript.
loading
Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model.
Buchmann, Stefan; Sandmann, Gunther H; Walz, Lars; Reichel, Thomas; Beitzel, Knut; Wexel, Gabriele; Tian, Weiwei; Battmann, Achim; Vogt, Stephan; Winter, Gerhard; Imhoff, Andreas B.
Afiliação
  • Buchmann S; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. stefan.buchmann@LRZ.tu-muenchen.de.
  • Sandmann GH; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. g_sandmann@hotmail.com.
  • Walz L; Department of Traumatology, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany. g_sandmann@hotmail.com.
  • Reichel T; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. lwalz@gmx.de.
  • Beitzel K; Clinical Trial Unit, University Hospital Basel, Schanzenstr. 55, Basel, Switzerland. lwalz@gmx.de.
  • Wexel G; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. thomasreichel87@gmail.com.
  • Tian W; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. beitzelknut@tum.de.
  • Battmann A; Department of Experimental Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany. gabriele.wexel@LRZ.tu-muenchen.de.
  • Vogt S; Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig Maximilians University, Butenandstr. 5-13, 81377, Munich, Germany. weiwei.tian@cup.uni-muenchen.de.
  • Winter G; Institute for Pathology and Cytodiagnostics, Urselerstr. 33, 61348, Bad Homburg, v.d.H, Germany. batcave66@gmx.de.
  • Imhoff AB; Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstr., 81675, Munich, Germany. stephan.vogt@LRZ.tu-muenchen.de.
BMC Musculoskelet Disord ; 16: 82, 2015 Apr 10.
Article em En | MEDLINE | ID: mdl-25888096
BACKGROUND: Biological augmentation of rotator cuff repair is of growing interest to improve biomechanical properties and prevent re-tearing. But intraoperative single shot growth factor application appears not sufficient to provide healing support in the physiologic growth factor expression peaks. The purpose of this study was to establish a sustained release of granulocyte-colony stimulating factor (G-CSF) from injectable vesicular phospholipid gels (VPGs) in vitro and to examine biocompatibility and influence on histology and biomechanical behavior of G-CSF loaded VPGs in a chronic supraspinatus tear rat model. METHODS: G-CSF loaded VPGs were produced by dual asymmetric centrifugation. In vitro the integrity, stability and release rate were analyzed. In vivo supraspinatus tendons of 60 rats were detached and after 3 weeks a transosseous refixation with G-CSF loaded VPGs augmentation (n = 15; control, placebo, 1 and 10 µg G-CSF/d) was performed. 6 weeks postoperatively the healing site was analyzed histologically (n = 9; H&E by modified MOVIN score/Collagen I/III) and biomechanically (n = 6). RESULTS: In vitro testing revealed stable proteins after centrifugation and a continuous G-CSF release of up to 4 weeks. Placebo VPGs showed histologically no negative side effects on the healing process. Histologically in vivo testing demonstrated significant advantages for G-CSF 1 µg/d but not for G-CSF 10 µg/d in Collagen III content (p = 0.035) and a higher Collagen I/III ratio compared to the other groups. Biomechanically G-CSF 1 µg/d revealed a significant higher load to failure ratio (p = 0.020) compared to control but no significant differences in stiffness. CONCLUSIONS: By use of VPGs a continuous growth factor release could be obtained in vitro. The in vivo results demonstrate an improvement of immunohistology and biomechanical properties with a low dose G-CSF application via VPG. The VPG itself was well tolerated and had no negative influence on the healing behavior. Due to the favorable properties (highly adhesive, injectable, biocompatible) VPGs are a very interesting option for biologic augmentation. The study may serve as basis for further research in growth factor application models.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfolipídeos / Traumatismos dos Tendões / Cicatrização / Portadores de Fármacos / Fator Estimulador de Colônias de Granulócitos / Manguito Rotador Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Musculoskelet Disord Assunto da revista: FISIOLOGIA / ORTOPEDIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfolipídeos / Traumatismos dos Tendões / Cicatrização / Portadores de Fármacos / Fator Estimulador de Colônias de Granulócitos / Manguito Rotador Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Musculoskelet Disord Assunto da revista: FISIOLOGIA / ORTOPEDIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha